share_log

醫思健康：截至2023年12月31止月份之股份發行人的證券變動月報表

EC HEALTHCARE: Monthly Return of Equity Issuer on Movements in Securities Ended 31 December 2023

香港交易所 ·  Jan 5 04:48
Summary by Moomoo AI
醫思健康（EC HEALTHCARE）於2024年1月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2023年12月31日的公司股份及證券變動情況。報告顯示，公司法定/註冊股本結存維持在38,000,000,000股，每股面值0.00001港元，總額380,000港元，本月無增減變動。在股份期權方面，根據2016年2月19日及2023年5月29日通過的購股權計劃，公司股份期權數目有所變動，其中一項計劃於本月內失效，導致8,000,000股份期權結存減少。此外，公司亦根據OrbiMed及GS的認股權證及可換股債券條款，發行了新股份，分別為5,899,513股及41,493,930股。該等證券變動均已獲得董事會正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
醫思健康（EC HEALTHCARE）於2024年1月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2023年12月31日的公司股份及證券變動情況。報告顯示，公司法定/註冊股本結存維持在38,000,000,000股，每股面值0.00001港元，總額380,000港元，本月無增減變動。在股份期權方面，根據2016年2月19日及2023年5月29日通過的購股權計劃，公司股份期權數目有所變動，其中一項計劃於本月內失效，導致8,000,000股份期權結存減少。此外，公司亦根據OrbiMed及GS的認股權證及可換股債券條款，發行了新股份，分別為5,899,513股及41,493,930股。該等證券變動均已獲得董事會正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
EC HEALTHCARE SUBMITTED ITS LATEST SECURITIES MONTHLY CHANGE REPORT TO HONG KONG TRADING AND SETTLEMENT LIMITED ON 5 JANUARY 2024, REPORTING THE CHANGES IN COMPANY SHARES AND SECURITIES AS OF 31 DECEMBER 2023. The report showed that the company's regulated/registered share capital remained at 38,000,000,000 shares with a face value of HK$0.00001 per share for a total of HK$380,000, unchanged this month. In terms of stock options, the number of stock options under the share option plans adopted on 19 February 2016 and 29 May 2023 changed the number of options for the company, one of which lapsed during this month, resulting in a decrease in the deposit of 8,000,000 share options. In addition, the Company issued new shares of 5,899,513 shares and 41,493,930 shares under the terms of the warrants and convertible bonds of OrbiMed and GS. The changes in these securities have been formally approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
EC HEALTHCARE SUBMITTED ITS LATEST SECURITIES MONTHLY CHANGE REPORT TO HONG KONG TRADING AND SETTLEMENT LIMITED ON 5 JANUARY 2024, REPORTING THE CHANGES IN COMPANY SHARES AND SECURITIES AS OF 31 DECEMBER 2023. The report showed that the company's regulated/registered share capital remained at 38,000,000,000 shares with a face value of HK$0.00001 per share for a total of HK$380,000, unchanged this month. In terms of stock options, the number of stock options under the share option plans adopted on 19 February 2016 and 29 May 2023 changed the number of options for the company, one of which lapsed during this month, resulting in a decrease in the deposit of 8,000,000 share options. In addition, the Company issued new shares of 5,899,513 shares and 41,493,930 shares under the terms of the warrants and convertible bonds of OrbiMed and GS. The changes in these securities have been formally approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more